메뉴 건너뛰기




Volumn 15, Issue 3, 2015, Pages 302-310

Factors associated with cognitive decline in older adults with type2 diabetes mellitus during a 6-year observation

Author keywords

Blood pressure; Hemoglobin A1c; High density lipoprotein cholesterol; Insulin; Renin angiotensin system blockers

Indexed keywords

ANTIDIABETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ORAL ANTIDIABETIC AGENT;

EID: 84924626265     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/ggi.12273     Document Type: Article
Times cited : (29)

References (50)
  • 1
    • 84924553098 scopus 로고    scopus 로고
    • [Cited 12 Feb 2014.]
    • Results of the National Health and Nutrition Survey Japan. 2007 [Cited 12 Feb 2014.] Available from URL: http://www0.nih.go.jp/eiken/english/research/pdf/nhns2007.pdf
    • (2007)
  • 3
    • 84871969895 scopus 로고    scopus 로고
    • Cognitive dysfunction: an emerging concept of a new diabetic complication in the elderly
    • Umegaki H, Hayashi T, Nomura H etal. Cognitive dysfunction: an emerging concept of a new diabetic complication in the elderly. Geriatr Gerontol Int 2013; 13: 28-34.
    • (2013) Geriatr Gerontol Int , vol.13 , pp. 28-34
    • Umegaki, H.1    Hayashi, T.2    Nomura, H.3
  • 4
    • 82255179765 scopus 로고    scopus 로고
    • Advanced glycation end product level, diabetes, and accelerated cognitive aging
    • Yaffe K, Lindquist K, Schwartz AV etal. Advanced glycation end product level, diabetes, and accelerated cognitive aging. Neurology 2011; 77: 1351-1356.
    • (2011) Neurology , vol.77 , pp. 1351-1356
    • Yaffe, K.1    Lindquist, K.2    Schwartz, A.V.3
  • 5
    • 84859498019 scopus 로고    scopus 로고
    • Neurodegeneration in diabetes mellitus
    • Umegaki H. Neurodegeneration in diabetes mellitus. Adv Exp Med Biol 2012; 724: 258-265.
    • (2012) Adv Exp Med Biol , vol.724 , pp. 258-265
    • Umegaki, H.1
  • 6
    • 84863198110 scopus 로고    scopus 로고
    • Effects of hyperglycemia and effects of ketosis on cerebral perfusion, cerebral water distribution, and cerebral metabolism
    • Glaser N, Ngo C, Anderson S etal. Effects of hyperglycemia and effects of ketosis on cerebral perfusion, cerebral water distribution, and cerebral metabolism. Diabetes 2012; 61: 1831-1837.
    • (2012) Diabetes , vol.61 , pp. 1831-1837
    • Glaser, N.1    Ngo, C.2    Anderson, S.3
  • 7
    • 78049272357 scopus 로고    scopus 로고
    • Impact of comorbid conditions and race/ethnicity on glycemic control among the US population with type 2 diabetes, 1988-1994 to 1999-2004
    • Suh DC, Choi IS, Plauschinat C etal. Impact of comorbid conditions and race/ethnicity on glycemic control among the US population with type 2 diabetes, 1988-1994 to 1999-2004. J Diabetes Complications 2010; 24: 382-391.
    • (2010) J Diabetes Complications , vol.24 , pp. 382-391
    • Suh, D.C.1    Choi, I.S.2    Plauschinat, C.3
  • 8
    • 77953821528 scopus 로고    scopus 로고
    • Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Emerging Risk Factors Collaboration
    • Sarwar N, Gao P, Seshasai SR etal. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Emerging Risk Factors Collaboration. Lancet 2010; 375: 2215-2222.
    • (2010) Lancet , vol.375 , pp. 2215-2222
    • Sarwar, N.1    Gao, P.2    Seshasai, S.R.3
  • 9
    • 0034641568 scopus 로고    scopus 로고
    • Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
    • Stratton IM, Adler AI, Neil HA etal. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-412.
    • (2000) BMJ , vol.321 , pp. 405-412
    • Stratton, I.M.1    Adler, A.I.2    Neil, H.A.3
  • 10
    • 80052400687 scopus 로고    scopus 로고
    • Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia
    • Gorelick PB, Scuteri A, Black SE etal. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Stroke 2011; 42: 2672-2713.
    • (2011) Stroke , vol.42 , pp. 2672-2713
    • Gorelick, P.B.1    Scuteri, A.2    Black, S.E.3
  • 11
    • 19444364576 scopus 로고    scopus 로고
    • Asymptomatic cerebral infarction on brain MR images and cognitive function in elderly diabetic patients
    • Araki A, Ito H. Asymptomatic cerebral infarction on brain MR images and cognitive function in elderly diabetic patients. Geriatr Gerontol Int 2002; 2: 206-214.
    • (2002) Geriatr Gerontol Int , vol.2 , pp. 206-214
    • Araki, A.1    Ito, H.2
  • 12
    • 47049129183 scopus 로고    scopus 로고
    • Glucose control levels, ischaemic brain lesions, and hyperinsulinaemia were associated with cognitive dysfunction in diabetic elderly
    • Umegaki H, Kawamura T, Mogi N etal. Glucose control levels, ischaemic brain lesions, and hyperinsulinaemia were associated with cognitive dysfunction in diabetic elderly. Age Ageing 2008; 37: 458-461.
    • (2008) Age Ageing , vol.37 , pp. 458-461
    • Umegaki, H.1    Kawamura, T.2    Mogi, N.3
  • 13
    • 80053619327 scopus 로고    scopus 로고
    • Endothelial and inflammatory markers in relation to progression of ischaemic cerebral small-vessel disease and cognitive impairment: a 6-year longitudinal study in patients with type 2 diabetes mellitus
    • Umemura T, Kawamura T, Umegaki H etal. Endothelial and inflammatory markers in relation to progression of ischaemic cerebral small-vessel disease and cognitive impairment: a 6-year longitudinal study in patients with type 2 diabetes mellitus. J Neurol Neurosurg Psychiatry 2011; 82: 1186-1194.
    • (2011) J Neurol Neurosurg Psychiatry , vol.82 , pp. 1186-1194
    • Umemura, T.1    Kawamura, T.2    Umegaki, H.3
  • 14
    • 80054907898 scopus 로고    scopus 로고
    • Does cerebral small vessel disease predict future decline of cognitive function in elderly people with type 2 diabetes?
    • Imamine R, Kawamura T, Umemura T etal. Does cerebral small vessel disease predict future decline of cognitive function in elderly people with type 2 diabetes? Diabetes Res Clin Pract 2011; 94: 91-99.
    • (2011) Diabetes Res Clin Pract , vol.94 , pp. 91-99
    • Imamine, R.1    Kawamura, T.2    Umemura, T.3
  • 15
    • 84857217561 scopus 로고    scopus 로고
    • International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values
    • Kashiwagi A, Kasuga M, Araki E etal. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Invest 2012; 3: 39-40.
    • (2012) J Diabetes Invest , vol.3 , pp. 39-40
    • Kashiwagi, A.1    Kasuga, M.2    Araki, E.3
  • 16
    • 65549111017 scopus 로고    scopus 로고
    • Revised equations for estimated glomerular filtration rate (GFR) from serum creatinine in Japan
    • Matsuo S, Imai E, Horio M etal. Revised equations for estimated glomerular filtration rate (GFR) from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
    • (2009) Am J Kidney Dis , vol.53 , pp. 982-992
    • Matsuo, S.1    Imai, E.2    Horio, M.3
  • 17
    • 0016823810 scopus 로고
    • "Mini-Mental State": a practical method of grading the cognitive function of patients or the clinician
    • Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method of grading the cognitive function of patients or the clinician. J Psychiatr Res 1978; 12: 189-198.
    • (1978) J Psychiatr Res , vol.12 , pp. 189-198
    • Folstein, M.F.1    Folstein, S.E.2    McHugh, P.R.3
  • 18
    • 0020960729 scopus 로고
    • The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy
    • Mohs RC, Rosen WG, Davis KL. The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull 1983; 19: 448-450.
    • (1983) Psychopharmacol Bull , vol.19 , pp. 448-450
    • Mohs, R.C.1    Rosen, W.G.2    Davis, K.L.3
  • 20
    • 57049145197 scopus 로고
    • Studies of interference in serial verbal reactions
    • Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935; 18: 643-662.
    • (1935) J Exp Psychol , vol.18 , pp. 643-662
    • Stroop, J.R.1
  • 21
    • 0002565032 scopus 로고
    • The use of self-rating depression scales in the elderly
    • In: Poon LW, ed. Washington, DC: American Psychological Association
    • Yesavage JA. The use of self-rating depression scales in the elderly. In: Poon LW, ed. Clinical Memory Assessment of Older Adults. Washington, DC: American Psychological Association, 1986; 213-217.
    • (1986) Clinical Memory Assessment of Older Adults , pp. 213-217
    • Yesavage, J.A.1
  • 22
    • 0023262989 scopus 로고
    • MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging
    • Fazekas F, Chawluk J, Alavi A etal. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987; 149: 351-356.
    • (1987) AJR Am J Roentgenol , vol.149 , pp. 351-356
    • Fazekas, F.1    Chawluk, J.2    Alavi, A.3
  • 23
    • 52449088634 scopus 로고    scopus 로고
    • Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study
    • Singh-Manoux A, Gimeno D, Kivimaki M etal. Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study. Arterioscler Thromb Vasc Biol 2008; 28: 1556-1562.
    • (2008) Arterioscler Thromb Vasc Biol , vol.28 , pp. 1556-1562
    • Singh-Manoux, A.1    Gimeno, D.2    Kivimaki, M.3
  • 24
    • 77951916345 scopus 로고    scopus 로고
    • Relationship between low levels of high-density lipoprotein cholesterol and dementia in the elderly. The InChianti study
    • Zuliani G, Cavalieri M, Galvani M etal. Relationship between low levels of high-density lipoprotein cholesterol and dementia in the elderly. The InChianti study. J Gerontol A Biol Sci Med Sci 2010; 65: 559-564.
    • (2010) J Gerontol A Biol Sci Med Sci , vol.65 , pp. 559-564
    • Zuliani, G.1    Cavalieri, M.2    Galvani, M.3
  • 25
    • 9144258067 scopus 로고    scopus 로고
    • Serum lipids and hippocampal volume: the link to Alzheimer's disease?
    • Wolf H, Hensel A, Arendt T etal. Serum lipids and hippocampal volume: the link to Alzheimer's disease? Ann Neurol 2004; 56: 745-758.
    • (2004) Ann Neurol , vol.56 , pp. 745-758
    • Wolf, H.1    Hensel, A.2    Arendt, T.3
  • 26
    • 78549235412 scopus 로고    scopus 로고
    • Low levels of high-density lipoprotein increase the severity of cerebral white matter changes: implications for prevention and treatment of cerebrovascular diseases
    • Crisby M, Bronge L, Wahlund LO. Low levels of high-density lipoprotein increase the severity of cerebral white matter changes: implications for prevention and treatment of cerebrovascular diseases. Curr Alzheimer Res 2010; 7: 534-539.
    • (2010) Curr Alzheimer Res , vol.7 , pp. 534-539
    • Crisby, M.1    Bronge, L.2    Wahlund, L.O.3
  • 27
    • 0035816031 scopus 로고    scopus 로고
    • High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study
    • Sacco RL, Benson RT, Kargman DE etal. High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. JAMA 2001; 285: 2729-2735.
    • (2001) JAMA , vol.285 , pp. 2729-2735
    • Sacco, R.L.1    Benson, R.T.2    Kargman, D.E.3
  • 28
    • 0032559575 scopus 로고    scopus 로고
    • Alzheimer's amyloid beta interaction with normal human plasma high-density lipoprotein: association with apolipoprotein and lipids
    • Koudinov AR, Berezov TT, Kumar A etal. Alzheimer's amyloid beta interaction with normal human plasma high-density lipoprotein: association with apolipoprotein and lipids. Clin Chim Acta 1998; 270: 75-84.
    • (1998) Clin Chim Acta , vol.270 , pp. 75-84
    • Koudinov, A.R.1    Berezov, T.T.2    Kumar, A.3
  • 29
    • 0034595080 scopus 로고    scopus 로고
    • High density lipoprotein inhibits assembly of amyloid beta-peptides into fibrils
    • Olesen OF, Dagø L. High density lipoprotein inhibits assembly of amyloid beta-peptides into fibrils. Biochem Biophys Res Commun 2000; 270: 62-66.
    • (2000) Biochem Biophys Res Commun , vol.270 , pp. 62-66
    • Olesen, O.F.1    Dagø, L.2
  • 30
    • 0035830376 scopus 로고    scopus 로고
    • Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation
    • Cockerill GW, Huehns TY, Weerasinghe A etal. Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation. Circulation 2001; 103: 108-112.
    • (2001) Circulation , vol.103 , pp. 108-112
    • Cockerill, G.W.1    Huehns, T.Y.2    Weerasinghe, A.3
  • 31
    • 1942467218 scopus 로고    scopus 로고
    • Reconstituted high-density lipoprotein exhibits neuroprotection in two rat models of stroke
    • Paternò R, Ruocco A, Postiglione A etal. Reconstituted high-density lipoprotein exhibits neuroprotection in two rat models of stroke. Cerebrovasc Dis 2004; 17: 204-211.
    • (2004) Cerebrovasc Dis , vol.17 , pp. 204-211
    • Paternò, R.1    Ruocco, A.2    Postiglione, A.3
  • 32
    • 1842454104 scopus 로고    scopus 로고
    • Arnesen Change in serum lipids and body mass index by age, sex, and smoking status: the Tromso study 1986-1995
    • Wilsgaard E. Arnesen Change in serum lipids and body mass index by age, sex, and smoking status: the Tromso study 1986-1995. Ann Epidemiol 2004; 14: 265-273.
    • (2004) Ann Epidemiol , vol.14 , pp. 265-273
    • Wilsgaard, E.1
  • 33
    • 0033064359 scopus 로고    scopus 로고
    • Exercise intensity: its effect on the high-density lipoprotein profile
    • Spate-Douglas T, Keyser RE. Exercise intensity: its effect on the high-density lipoprotein profile. Arch Phys Med Rehabil 1999; 80: 691-695.
    • (1999) Arch Phys Med Rehabil , vol.80 , pp. 691-695
    • Spate-Douglas, T.1    Keyser, R.E.2
  • 34
    • 0141737742 scopus 로고    scopus 로고
    • The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis
    • Maeda K, Noguchi Y, Fukui T. The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis. Prev Med 2003; 37: 283-290.
    • (2003) Prev Med , vol.37 , pp. 283-290
    • Maeda, K.1    Noguchi, Y.2    Fukui, T.3
  • 35
    • 0026628813 scopus 로고
    • Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol
    • Hannuksela M, Marcel YL, Kesaniemi YA etal. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res 1992; 33: 737-744.
    • (1992) J Lipid Res , vol.33 , pp. 737-744
    • Hannuksela, M.1    Marcel, Y.L.2    Kesaniemi, Y.A.3
  • 36
    • 11844296800 scopus 로고    scopus 로고
    • Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials
    • Birjmohun RS, Hutten BA, Kastelein JJ etal. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials. J Am Coll Cardiol 2005; 45: 185-197.
    • (2005) J Am Coll Cardiol , vol.45 , pp. 185-197
    • Birjmohun, R.S.1    Hutten, B.A.2    Kastelein, J.J.3
  • 37
    • 84860112460 scopus 로고    scopus 로고
    • The renin-angiotensin system and antihypertensive drugs in Alzheimer's disease: current standing of the angiotensin hypothesis?
    • Kehoe PG, Passmore PA. The renin-angiotensin system and antihypertensive drugs in Alzheimer's disease: current standing of the angiotensin hypothesis? J Alzheimers Dis 2012; 30 (Suppl 2): S251-S268.
    • (2012) J Alzheimers Dis , vol.30 , pp. S251-S268
    • Kehoe, P.G.1    Passmore, P.A.2
  • 38
    • 84855185039 scopus 로고    scopus 로고
    • Standards of Medical Care in Diabetes
    • American diabetes asscociation. Standards of Medical Care in Diabetes. Diabetes Care 2012; 35: S11-S63.
    • (2012) Diabetes Care , vol.35 , pp. S11-S63
  • 39
    • 78649444829 scopus 로고    scopus 로고
    • The relationship between blood pressure and cognitive function
    • Novak V, Hajjar I. The relationship between blood pressure and cognitive function. Nat Rev Cardiol 2010; 7: 686-698.
    • (2010) Nat Rev Cardiol , vol.7 , pp. 686-698
    • Novak, V.1    Hajjar, I.2
  • 40
    • 0030955583 scopus 로고    scopus 로고
    • Blood pressure and performance on the Mini-Mental State Examination in the very old. Cross-sectional and longitudinal data from the Kungsholmen Project
    • Guo Z, Fratiglioni L, Winblad B etal. Blood pressure and performance on the Mini-Mental State Examination in the very old. Cross-sectional and longitudinal data from the Kungsholmen Project. Am J Epidemiol 1997; 145: 1106-1113.
    • (1997) Am J Epidemiol , vol.145 , pp. 1106-1113
    • Guo, Z.1    Fratiglioni, L.2    Winblad, B.3
  • 41
    • 34047235497 scopus 로고    scopus 로고
    • Low systolic blood pressure is associated with impaired cognitive function in the oldest old: longitudinal observations in a population-based sample 80 years and older
    • Nilsson SE, Read S, Berg S etal. Low systolic blood pressure is associated with impaired cognitive function in the oldest old: longitudinal observations in a population-based sample 80 years and older. Aging Clin Exp Res 2007; 19: 41-47.
    • (2007) Aging Clin Exp Res , vol.19 , pp. 41-47
    • Nilsson, S.E.1    Read, S.2    Berg, S.3
  • 42
    • 84856256660 scopus 로고    scopus 로고
    • Better cognitive and physical performance is associated with higher blood pressure in centenarians
    • Szewieczek J, Dulawa J, Gminski J etal. Better cognitive and physical performance is associated with higher blood pressure in centenarians. J Nutr Health Aging 2011; 15: 618-622.
    • (2011) J Nutr Health Aging , vol.15 , pp. 618-622
    • Szewieczek, J.1    Dulawa, J.2    Gminski, J.3
  • 43
    • 33745447477 scopus 로고    scopus 로고
    • Executive function and the frontal lobes: a meta-analytic review
    • Alvarez JA, Emory E. Executive function and the frontal lobes: a meta-analytic review. Neuropsychol Rev 2006; 16: 17-42.
    • (2006) Neuropsychol Rev , vol.16 , pp. 17-42
    • Alvarez, J.A.1    Emory, E.2
  • 44
    • 77956183886 scopus 로고    scopus 로고
    • Insulin-resistance and metabolic syndrome are related to executive function in women in a large family-based study
    • Schuur M, Henneman P, van Swieten JC etal. Insulin-resistance and metabolic syndrome are related to executive function in women in a large family-based study. Eur J Epidemiol 2010; 25: 561-568.
    • (2010) Eur J Epidemiol , vol.25 , pp. 561-568
    • Schuur, M.1    Henneman, P.2    van Swieten, J.C.3
  • 45
    • 77952998595 scopus 로고    scopus 로고
    • Cognitive impairment in nondiabetic middle-aged and older adults is associated with insulin resistance
    • Bruehl H, Sweat V, Hassenstab J etal. Cognitive impairment in nondiabetic middle-aged and older adults is associated with insulin resistance. J Clin Exp Neuropsychol 2010; 32: 487-493.
    • (2010) J Clin Exp Neuropsychol , vol.32 , pp. 487-493
    • Bruehl, H.1    Sweat, V.2    Hassenstab, J.3
  • 46
    • 84866062805 scopus 로고    scopus 로고
    • Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia
    • Yaffe K, Falvey C, Hamilton N etal. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol 2012; 69: 1170-1175.
    • (2012) Arch Neurol , vol.69 , pp. 1170-1175
    • Yaffe, K.1    Falvey, C.2    Hamilton, N.3
  • 47
    • 77950354771 scopus 로고    scopus 로고
    • Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study
    • Marioni RE, Strachan MW, Reynolds RM etal. Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 2010; 59: 710-713.
    • (2010) Diabetes , vol.59 , pp. 710-713
    • Marioni, R.E.1    Strachan, M.W.2    Reynolds, R.M.3
  • 48
    • 77958021269 scopus 로고    scopus 로고
    • Utrecht Diabetic Encephalopathy Study Group. Microvascular determinants of cognitive decline and brain volume change in elderly patients with type 2 diabetes
    • de Bresser J, Reijmer YD, van den Berg E etal. Utrecht Diabetic Encephalopathy Study Group. Microvascular determinants of cognitive decline and brain volume change in elderly patients with type 2 diabetes. Dement Geriatr Cogn Disord 2010; 30: 381-386.
    • (2010) Dement Geriatr Cogn Disord , vol.30 , pp. 381-386
    • de Bresser, J.1    Reijmer, Y.D.2    van den Berg, E.3
  • 49
    • 84858782892 scopus 로고    scopus 로고
    • Japanese Elderly Diabetes Intervention Trial Study Group. Risk factors associated with cognitive decline in the elderly with type 2 diabetes: baseline data analysis of the Japanese Elderly Diabetes Intervention Trial
    • Umegaki H, Iimuro S, Shinozaki T etal. Japanese Elderly Diabetes Intervention Trial Study Group. Risk factors associated with cognitive decline in the elderly with type 2 diabetes: baseline data analysis of the Japanese Elderly Diabetes Intervention Trial. Geriatr Gerontol Int 2012; 12 (Suppl 1): 103-109.
    • (2012) Geriatr Gerontol Int , vol.12 , pp. 103-109
    • Umegaki, H.1    Iimuro, S.2    Shinozaki, T.3
  • 50
    • 79959479102 scopus 로고    scopus 로고
    • Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease
    • Sato T, Hanyu H, Hirao K etal. Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease. Neurobiol Aging 2011; 32: 1626-1633.
    • (2011) Neurobiol Aging , vol.32 , pp. 1626-1633
    • Sato, T.1    Hanyu, H.2    Hirao, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.